411 related articles for article (PubMed ID: 15616597)
21. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
22. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.
Zanta-Boussif MA; Charrier S; Brice-Ouzet A; Martin S; Opolon P; Thrasher AJ; Hope TJ; Galy A
Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615
[TBL] [Abstract][Full Text] [Related]
23. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.
Wada T; Jagadeesh GJ; Nelson DL; Candotti F
Hum Gene Ther; 2002 Jun; 13(9):1039-46. PubMed ID: 12067437
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.
Dupré L; Trifari S; Follenzi A; Marangoni F; Lain de Lera T; Bernad A; Martino S; Tsuchiya S; Bordignon C; Naldini L; Aiuti A; Roncarolo MG
Mol Ther; 2004 Nov; 10(5):903-15. PubMed ID: 15509508
[TBL] [Abstract][Full Text] [Related]
25. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.
Gallego MD; de la Fuente MA; Anton IM; Snapper S; Fuhlbrigge R; Geha RS
Int Immunol; 2006 Feb; 18(2):221-32. PubMed ID: 16141245
[TBL] [Abstract][Full Text] [Related]
26. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
[TBL] [Abstract][Full Text] [Related]
27. The Wiskott-Aldrich syndrome.
Ochs HD
Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
[TBL] [Abstract][Full Text] [Related]
28. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
Andreu N; Aran JM; Fillat C
Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
[TBL] [Abstract][Full Text] [Related]
29. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
Curcio C; Pannellini T; Lanzardo S; Forni G; Musiani P; Antón IM
J Pathol; 2007 Jan; 211(1):67-75. PubMed ID: 17086554
[TBL] [Abstract][Full Text] [Related]
30. WASp in immune-system organization and function.
Thrasher AJ
Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
[TBL] [Abstract][Full Text] [Related]
31. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.
Wada T; Konno A; Schurman SH; Garabedian EK; Anderson SM; Kirby M; Nelson DL; Candotti F
J Clin Invest; 2003 May; 111(9):1389-97. PubMed ID: 12727931
[TBL] [Abstract][Full Text] [Related]
32. Expression of WASP and Scar1/WAVE1 actin-associated proteins is differentially modulated during differentiation of HL-60 cells.
Launay S; Brown G; Machesky LM
Cell Motil Cytoskeleton; 2003 Apr; 54(4):274-85. PubMed ID: 12601690
[TBL] [Abstract][Full Text] [Related]
33. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
34. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
35. Contributions of Wiskott-Aldrich syndrome family cytoskeletal regulatory adapters to immune regulation.
Zhang J; Dong B; Siminovitch KA
Immunol Rev; 2009 Nov; 232(1):175-94. PubMed ID: 19909364
[TBL] [Abstract][Full Text] [Related]
36. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.
Charrier S; Dupré L; Scaramuzza S; Jeanson-Leh L; Blundell MP; Danos O; Cattaneo F; Aiuti A; Eckenberg R; Thrasher AJ; Roncarolo MG; Galy A
Gene Ther; 2007 Mar; 14(5):415-28. PubMed ID: 17051251
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
39. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
40. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
